Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 35.12%9.18B | 17.29%4.11B | 62.08%6.79B | 120.72%3.5B | 56.64%4.19B | 25.70%1.59B | -26.07%2.68B | -31.08%1.26B | 7.02%3.62B | --2.6B |
| Operating income | 35.12%9.18B | 17.29%4.11B | 62.08%6.79B | 120.72%3.5B | 56.64%4.19B | 25.70%1.59B | -26.07%2.68B | -31.08%1.26B | 7.02%3.62B | 2.6B |
| Cost of sales | -28.52%-2.16B | -22.26%-1.01B | -43.70%-1.68B | -67.40%-822.52M | -20.04%-1.17B | -10.95%-491.34M | 22.46%-975.7M | 27.62%-442.85M | -5.29%-1.26B | ---903.55M |
| Operating expenses | -28.52%-2.16B | -22.26%-1.01B | -43.70%-1.68B | -67.40%-822.52M | -20.04%-1.17B | -10.95%-491.34M | 22.46%-975.7M | 27.62%-442.85M | -5.29%-1.26B | -903.55M |
| Gross profit | 37.29%7.01B | 15.77%3.1B | 69.22%5.11B | 144.63%2.68B | 77.65%3.02B | 33.67%1.1B | -28.00%1.7B | -32.82%819.54M | 7.96%2.36B | 1.69B |
| Selling expenses | -35.86%-5.36B | -15.88%-2.34B | -76.19%-3.95B | -137.08%-2.02B | -78.13%-2.24B | -39.93%-850.58M | 20.01%-1.26B | 22.86%-607.88M | -2.38%-1.57B | ---1.12B |
| Administrative expenses | -32.00%-320.45M | -34.33%-152.81M | -15.82%-242.76M | -1.63%-113.76M | 6.17%-209.61M | -9.10%-111.94M | 14.65%-223.39M | 20.58%-102.6M | 0.76%-261.72M | ---190.66M |
| Research and development expenses | -24.93%-224.7M | -31.68%-103.14M | -42.96%-179.87M | -44.00%-78.32M | -14.08%-125.81M | -4.75%-54.39M | -5.28%-110.28M | -4.35%-51.93M | -35.37%-104.75M | ---71.66M |
| Impairment and provision | -67.74%-11.69M | 35.94%-3.19M | -145.69%-6.97M | -133.82%-4.99M | 226.53%15.25M | 2,094.86%14.74M | -91.24%-12.05M | 74.96%-739K | -235.67%-6.3M | ---4.55M |
| -Other impairment is provision | -67.74%-11.69M | 35.94%-3.19M | -145.69%-6.97M | -133.82%-4.99M | 226.53%15.25M | 2,094.86%14.74M | -91.24%-12.05M | 74.96%-739K | -235.67%-6.3M | ---4.55M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 25.54%-9.79M | 48.31%-20.93M | ---16.62M |
| Special items of operating profit | 51.97%307.23M | 1,806.73%160.68M | 65.03%202.16M | -81.54%8.43M | 53.66%122.5M | 42.01%45.65M | 485.52%79.72M | 197.09%32.14M | 248.03%13.62M | --5.28M |
| Operating profit | 50.04%1.4B | 40.55%667.15M | 60.75%934.66M | 241.58%474.67M | 230.49%581.45M | 76.46%138.96M | -56.91%175.94M | -61.33%78.75M | 46.99%408.27M | 295.12M |
| Financing cost | -21.82%-7.4M | 11.28%-2.8M | 62.58%-6.07M | 72.93%-3.16M | 20.74%-16.23M | ---11.66M | ---20.47M | ---- | ---- | ---- |
| Share of profits of associates | -34.40%1.49M | 205.28%797K | 268.22%2.28M | 73.74%-757K | -10.09%-1.35M | -648.83%-2.88M | -724.83%-1.23M | -187.90%-385K | -108.00%-149K | --165K |
| Share of profit from joint venture company | ---- | ---- | 16.40%-3.89M | ---2.24M | ---4.65M | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 50.64%1.4B | 41.97%665.15M | 65.76%926.97M | 276.56%468.51M | 262.58%559.21M | 58.76%124.42M | -62.21%154.23M | -61.60%78.37M | 45.95%408.12M | 295.28M |
| Tax | -95.85%-242.21M | -95.32%-109.55M | -26.78%-123.67M | -138.86%-56.09M | -468.74%-97.55M | -50.65%-23.48M | 75.27%-17.15M | 47.74%-15.59M | 9.28%-69.35M | ---47.13M |
| After-tax profit from continuing operations | 43.68%1.15B | 34.72%555.6M | 74.00%803.3M | 308.59%412.43M | 236.78%461.66M | 60.78%100.94M | -59.54%137.08M | -63.97%62.78M | 66.73%338.77M | 248.16M |
| Earning after tax | 43.68%1.15B | 34.72%555.6M | 74.00%803.3M | 308.59%412.43M | 236.78%461.66M | 60.78%100.94M | -59.54%137.08M | -63.97%62.78M | 66.73%338.77M | 248.16M |
| Minority profit | 133.75%51.64M | 180.10%31.44M | 3,852.06%22.09M | 41,677.78%11.23M | 105.58%559K | 98.94%-27K | -8,541.38%-10.02M | -641.45%-2.56M | 57.82%-116K | --709K |
| Profit attributable to shareholders | 41.14%1.1B | 30.65%524.16M | 69.42%781.21M | 297.36%401.2M | 213.45%461.1M | 54.52%100.97M | -56.59%147.1M | -62.58%65.34M | 66.56%338.89M | 247.45M |
| Basic earnings per share | 41.33%2.77 | 30.69%1.32 | 68.97%1.96 | 304.00%1.01 | 182.93%1.16 | 38.89%0.25 | -56.38%0.41 | -63.27%0.18 | 64.91%0.94 | 0.69 |
| Diluted earnings per share | 41.33%2.77 | 30.69%1.32 | 68.97%1.96 | 304.00%1.01 | 182.93%1.16 | 38.89%0.25 | -56.38%0.41 | -63.27%0.18 | 64.91%0.94 | 0.69 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.